National and Kapodistrian University of Athens
Μελέτη της αρτηριακής κυκλοφορίας του εγκεφάλου με χρήση διακρανιακού Doppler σε ασθενείς με ενδιάμεση μεσογειακή αναιμία. Αξιολόγηση αποτελεσμάτων ως δείκτη κινδύνου εγκεφαλικού επεισοδίου
Abstract
dc:descriptionCerebrovascular accidents, either overt strokes or silent infarcts, consist a well-known complication in patients with hemoglobinopathies, especially with sickle cell disease. During the last years, transcranial Doppler(TCD) has become an essential methos in screening patients with sickle cell disease (SCD) at risk for stroke and has contributed in diminishing strokes in this group of patients.Patients with thalassemia intermedia (TI) are also at risk for brain ischemia, essentially for silent infarcts.The purpose of this study was to evaluate the role of TCD in the assessment of TI patients at risk for brain ischemia.We included in our study 44 patients followed in the Thalassemia Unit of the 1st Department of Pediatrics of the University of Athens, 35 with TI and 9 with SCD.All of these patients had benefitted of a TCD examination with the use of a non-imaging TCD machine. The Time-averaged mean of the maximum velocity- TAMMV, peak velocity, pulsatility and resistive index were measured in the anterior, middle, posterior cerebral arteries and basilar artery. TAMMV values were compared to normal values referred in literature. Nine patients underwent brain MRI/MRA.We have also measured serum levels of NSE and S100 proteins, that are considered as biomarkers of glial cell and neuronal loss in order to find a possible relation between these proteins and TCD, which is considered as an index of brain ischemia.Twenty-nine out of 35 patients presented TAMMV values higher than normal in ≥1 of examined vessels. None of them, however, had TAMMV or peak velocity values higher than the established risk criteria for SCD patients. One patient had findings consistent with silent infarct on MRI without, however, signs of vasculopathy on MRA. This patient presented higher values of TAMMV and peak velocities compared to other TI patients.When we compared splenectomised to non-splenectomised TI patients, we found no statistical significant difference in TAMMV and peak velocities, PI and RI, despite the statistical significant difference in platelet count levels. Consequently, despite the increased risk of hypercoagulability and of thromboembolic/ischemic events in splenectomised patients there was no influence in TCD parameters.Considering NSE and S100 levels, there was a high correlation between the serum levels of S100 and TAMVV/ peak velocity of the left MCA. There was also a high correlation between NSE values and RI/PI of the left MCA. This finding shows the presence of correlation between biomarkers of neuronal/glial loss and markers of cerebral blood flow.There was also a high correlation between levels of NSE and LDH, that is between a hemolysis index and a neuronal loss biomarker, showing a possible etiologic relation between neuronal loss, hemolysis and alterations in NO levels in TI patients.In conclusion, our results are in favour of the hypothesis that TCD is helpful in assessing the risk of brain ischemia in TI patients, it cannot however discriminate high from low risk patients as in SCD. Our results also imply that silent infarcts in patients with TI are due not to macroangiopathy of cerebral vessels but to microangiopathy or venous thromboembolic events. Finally, they strengthen the hypothesis that neuronal loss in TI patients is related to hemolysis and NO levels alterations in these patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kanavaki, Aikaterini
- Καναβάκη, Αικατερίνη
Subjects
dc:subject × 19- Διακρανιακό Doppler
- Ενδιάμεση μεσογειακή αναιμία
- Ισχαιμικό αγγειακό εγκεφαλικό επεισόδιο
- Σιωπηρό έμφρακτο
- Πρόληψη
- Μέση ταχύτητα
- Transcranial doppler
- Thalassemia intermedia
- Cerebrovascular accident (C.V.A)
- Stroke
- Silent infarct
- Screening
- S100-B protein
- Neuron specific enolase
- Time averaged maximum mean velocity
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40790